Back to Search

CELU

Celularity Inc. Class A Common Stock
Data: 2026-11-03
$0.8084
Price
2.17%
Change
$2.55
52W High
$0.56
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Nov 03, 2026

58.1

AI Score

HOLD

0.15

Volume Ratio

Nov 13, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

CELU Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

CELU Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

CELU Options - Sort by Max open Interest (near term)

3rd November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CELU Daily Out of Money Options - Sort by Max open Interest (near term)

3rd November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CELU Daily In the Money Options - Sort by Max open Interest (near term)

3rd November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CELU Most Active Options by Volume(near term)

3rd November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
CELU Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CELU Stock Summary

Last updated Nov 03, 2026

CELU is currently trading at $0.8084, positioned below its 200-day moving average of $1.08, suggesting bearish momentum. The stock has a 52-week range of $0.5601 to $2.55.

Technical Analysis: The 50-day moving average stands at $1.32, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.464, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.474, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CELU at 58.1/100 with a HOLD recommendation.

CELU (Celularity Inc. Class A Common Stock) Indicators

Last updated Nov 03, 2026

Indicator Value
RSI(14) 36.464
CMF (20) -0.474
ROC (10) -35.698
ADX (14) 24.971
Indicator Value
MACD (12,26,9) -0.145
AROONOSC (14) -57.143
WILLAMS %R (14) -78.232
MFI (14) 22.596

CELU Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Nov 03 Gravestone Doji Bullish 55.2% +2.2 pts 21200
Nov 02 Gravestone Doji Bullish 55.2% +2.2 pts 21200
Oct 30 Inverted Hammer Bullish 56.4% +3.4 pts 19834
Oct 29 Marubozu (bearish) (contrarian — textbook says the opposite) Bullish 56.2% +3.2 pts 30540
Oct 27 Gravestone Doji Bullish 55.2% +2.2 pts 21200
Oct 21 Marubozu (bearish) (contrarian — textbook says the opposite) Bullish 56.2% +3.2 pts 30540

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

Celularity Inc. Class A Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

CELU Moving Averages Analysis

CELU (Celularity Inc. Class A Common Stock) Simple Moving Averages

Moving Averages are last updated Nov 03, 2026

Days MA
10 0.88
20 1.12
30 1.22
50 1.32
100 1.02
200 1.08

CELU Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 26.0 million
Earnings/Share ($) -1.69
Net Profit Margin (%) -2.4568
Dividend/Share ($) --
EPS Estimate Current Year ($) --
EPS Estimate Next Year ($) --
WallStreet Target Price ($) 2.50
Most Recent Quarter

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.